Fouadhassan

Moderna testing 70$

看多
Fouadhassan 已更新   
NASDAQ:MRNA   Moderna, Inc.
Moderna has benefit a lot from COVID time and coming with Vaccine is huge win lining the way for more products with mRNA tech , breaking 70$ it may go back up with good news on test results that, so far no major side effect found i hope they make success , this will justify easy 130$
交易結束:目標達成:
target reached at 90 , 112 and 146 closed and waiting entry back near 100 $
交易結束:目標達成:
recent target 185 reached

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。